These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8837835)

  • 1. [Cyclosporin A in inflammatory rheumatic diseases].
    Gross WL; Rob PM
    Internist (Berl); 1996 Jan; 37(1):91-7. PubMed ID: 8837835
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclosporin in treatment of glomerular diseases].
    Krieter DH; Müller GA
    Internist (Berl); 1996 Jan; 37(1):84-8. PubMed ID: 8837833
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
    Dadlani C; Orlow SJ
    J Am Acad Dermatol; 2005 Feb; 52(2):316-40. PubMed ID: 15692480
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of cyclosporin A in the treatment of autoimmune disorders].
    Kurki P
    Duodecim; 1999; 115(6):659-66. PubMed ID: 11859500
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporin in psoriasis: how?
    Feldman SR; Garton R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):250-3. PubMed ID: 15096128
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interstitial cystitis--cyclosporin A has better outcome than pentosan polysulfate sodium].
    Witte F
    Aktuelle Urol; 2007 Jan; 38(1):4-6. PubMed ID: 17290324
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prospects of the use of cyclosporin A in rheumatic diseases].
    Nasonov EL; Shtutman VZ; Nasonova VA
    Klin Med (Mosk); 1994; 72(5):12-9. PubMed ID: 7853807
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 1: rheumatologic and renal diseases.
    Langford CA; Klippel JH; Balow JE; James SP; Sneller MC
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):1021-8. PubMed ID: 9625665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [General principles of immunosuppressive therapy of diseases of rheumatic origin].
    Peter HH
    Internist (Berl); 1997 Jun; 38(6):514-9. PubMed ID: 9264996
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of T cell costimulation: an emerging therapeutic strategy for autoimmune rheumatic diseases.
    Daikh DI; Gillis J; Wofsy D
    Arthritis Rheum; 2006 Apr; 55(2):322-4. PubMed ID: 16583382
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cyclosporin-A therapy in autoimmune diseases].
    Patakfalvi A
    Orv Hetil; 1996 Sep; 137(35):1921-7. PubMed ID: 8927346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mAbs in nonlupus autoimmune rheumatic disease.
    Whelan BR; Isenberg DA
    Curr Opin Hematol; 2009 Jul; 16(4):280-4. PubMed ID: 19444098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical implication of cyclosporin for systemic autoimmune diseases: relevance to multidrug resistance].
    Tanaka Y; Tujimura S; Saito K; Kohno K
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):110-4. PubMed ID: 11963168
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment with tacrolimus in autoimmune diseases].
    Sádaba B; Azanza JR; García Quetglas E; Fernández V
    Rev Med Univ Navarra; 2004; 48(3):24-38. PubMed ID: 15622922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes.
    Vassilopoulos D
    Eur J Intern Med; 2011 Dec; 22(6):572-5. PubMed ID: 22075282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection.
    Galeazzi M; Bellisai F; Giannitti C; Manganelli S; Morozzi G; Sebastiani GD
    Ann N Y Acad Sci; 2007 Sep; 1110():544-9. PubMed ID: 17911470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
    Ferraccioli GF; Tomietto P; De Santis M
    Ann N Y Acad Sci; 2005 Jun; 1051():658-65. PubMed ID: 16127006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In which rheumatologic diseases is the immunologic etiology of importance?].
    Lenoch F
    Z Gesamte Inn Med; 1969 May; 24(9):136-9. PubMed ID: 5306827
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine: therapeutic effects in rheumatic diseases.
    Amor B; Dougados M
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):218-23. PubMed ID: 3289207
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic principles of immunopharmacology].
    Floersheim GL
    Clin Ter; 1981 Jan; 96(1):3-10. PubMed ID: 7237947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.